• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植受者移植前肾功能障碍与终末期肾病风险。

Risk of end-stage renal disease among liver transplant recipients with pretransplant renal dysfunction.

机构信息

Nephrology Division, Children's Hospital of Philadelphia, Philadelphia, PA, USA.

出版信息

Am J Transplant. 2012 Nov;12(11):2958-65. doi: 10.1111/j.1600-6143.2012.04177.x. Epub 2012 Jul 3.

DOI:10.1111/j.1600-6143.2012.04177.x
PMID:22759237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3527009/
Abstract

Guidelines recommend restricting simultaneous liver-kidney (SLK) transplant to candidates with prolonged dialysis or estimated glomerular filtration rate (eGFR) <30 mL/min/1.73m(2) for 90 days. However, few studies exist to support the latter recommendation. Using Scientific Registry of Transplant Recipients and Medicare dialysis data, we assembled a cohort of 4997 liver transplant recipients from February 27, 2002-January 1, 2008. Serial eGFRs were calculated from serum creatinines submitted with MELD reports. We categorized recipients by eGFR patterns in the 90 days pretransplant: Group 1 (eGFR always >30), Group 2 (eGFR fluctuated), Group 3 (eGFR always <30) and Group 4 (short-term dialysis). For Group 2, we characterized fluctuations in renal function using time-weighted mean eGFR. Among liver-alone recipients in Group 3, the rate of end-stage renal disease (ESRD) by 3 years was 31%, versus <10% for other groups (p < 0.001). In multivariable Cox regression, eGFR Group, diabetes (HR 2.65, p < 0.001) and black race (HR 1.83, p = 0.02) were associated with ESRD. Among liver-alone recipients in Group 2, only diabetics with time-weighted mean eGFR <30 had a substantial ESRD risk (25.6%). In summary, among liver transplant candidates not on prolonged dialysis, SLK should be considered for those whose eGFR is always <30 and diabetic candidates whose weighted mean eGFR is <30 for 90 days.

摘要

指南建议将同时进行肝-肾(SLK)移植限制在透析时间延长或估计肾小球滤过率(eGFR)<30 mL/min/1.73m(2) 90 天的患者。然而,很少有研究支持后者的建议。使用 Scientific Registry of Transplant Recipients 和 Medicare 透析数据,我们从 2002 年 2 月 27 日至 2008 年 1 月 1 日,组装了一个包含 4997 例肝移植受者的队列。血清肌酐报告中的 eGFR 从血清肌酐计算。我们根据移植前 90 天的 eGFR 模式对受者进行分类:第 1 组(eGFR 始终>30)、第 2 组(eGFR 波动)、第 3 组(eGFR 始终<30)和第 4 组(短期透析)。对于第 2 组,我们使用时间加权平均 eGFR 来描述肾功能的波动。在第 3 组的单纯肝移植受者中,3 年内终末期肾病(ESRD)的发生率为 31%,而其他组的发生率<10%(p<0.001)。在多变量 Cox 回归中,eGFR 组、糖尿病(HR 2.65,p<0.001)和黑人种族(HR 1.83,p=0.02)与 ESRD 相关。在第 2 组的单纯肝移植受者中,只有时间加权平均 eGFR<30 的糖尿病患者有较高的 ESRD 风险(25.6%)。总之,在未进行长期透析的肝移植候选者中,对于 eGFR 始终<30 的患者和 90 天内加权平均 eGFR<30 的糖尿病候选者,应考虑进行 SLK。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13d/3527009/c2712dbda2e1/nihms381057f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13d/3527009/34b97a2a023a/nihms381057f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13d/3527009/337857e77f40/nihms381057f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13d/3527009/c2712dbda2e1/nihms381057f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13d/3527009/34b97a2a023a/nihms381057f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13d/3527009/337857e77f40/nihms381057f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c13d/3527009/c2712dbda2e1/nihms381057f3.jpg

相似文献

1
Risk of end-stage renal disease among liver transplant recipients with pretransplant renal dysfunction.肝移植受者移植前肾功能障碍与终末期肾病风险。
Am J Transplant. 2012 Nov;12(11):2958-65. doi: 10.1111/j.1600-6143.2012.04177.x. Epub 2012 Jul 3.
2
Association of Pretransplant Renal Function With Liver Graft and Patient Survival After Liver Transplantation in Patients With Nonalcoholic Steatohepatitis.非酒精性脂肪性肝炎患者肝移植前肾功能与肝移植后肝移植物及患者生存的相关性
Liver Transpl. 2019 Mar;25(3):399-410. doi: 10.1002/lt.25367.
3
Simultaneous heart-kidney transplant compared with heart transplant alone in patients with borderline renal function who are not dialysis dependent.边缘肾功能且不依赖透析的患者中,心脏-肾脏联合移植与单纯心脏移植的比较。
J Thorac Cardiovasc Surg. 2024 Jul;168(1):149-160.e15. doi: 10.1016/j.jtcvs.2023.10.007. Epub 2023 Oct 12.
4
Delayed Graft Function in Simultaneous Liver Kidney Transplantation.肝肾联合移植中移植肾功能延迟。
Transplantation. 2020 Mar;104(3):542-550. doi: 10.1097/TP.0000000000002908.
5
Duration of end-stage renal disease and kidney transplant outcome.终末期肾病的病程与肾移植结果。
Nephrol Dial Transplant. 2005 Jan;20(1):167-75. doi: 10.1093/ndt/gfh541. Epub 2004 Nov 16.
6
Outcomes and native renal recovery following simultaneous liver-kidney transplantation.肝肾联合移植后结局和原肾恢复情况。
Am J Transplant. 2012 Nov;12(11):2949-57. doi: 10.1111/j.1600-6143.2012.04182.x. Epub 2012 Jul 3.
7
Liver Transplant Recipients With End-Stage Renal Disease Largely Benefit From Kidney Transplantation.患有终末期肾病的肝移植受者在很大程度上受益于肾移植。
Transplant Proc. 2018 Jan-Feb;50(1):202-210. doi: 10.1016/j.transproceed.2017.11.009.
8
Variation in Dialysis Exposure Prior to Nonpreemptive Living Donor Kidney Transplantation in the United States and Its Association With Allograft Outcomes.美国非优先活体供肾移植前透析暴露的差异及其与移植物结局的关系。
Am J Kidney Dis. 2018 May;71(5):636-647. doi: 10.1053/j.ajkd.2017.11.012. Epub 2018 Feb 1.
9
Pre-liver transplant renal dysfunction and association with post-transplant end-stage renal disease: A single-center examination of updated UNOS recommendations.肝移植前肾功能障碍与移植后终末期肾病的关系:UNOS 最新建议的单中心检查。
Clin Transplant. 2018 Dec;32(12):e13428. doi: 10.1111/ctr.13428. Epub 2018 Dec 14.
10
Association between a change in donor kidney function and long-term allograft outcomes in kidney transplant recipients.肾移植受者供肾肾功能变化与长期移植肾结局之间的关联
Artif Organs. 2015 Mar;39(3):254-9. doi: 10.1111/aor.12367. Epub 2014 Sep 10.

引用本文的文献

1
Influence of portal hypertension-associated upper gastrointestinal bleeding and acute kidney injury on liver transplantation prognosis.门静脉高压相关性上消化道出血及急性肾损伤对肝移植预后的影响。
Perioper Med (Lond). 2025 Jun 3;14(1):61. doi: 10.1186/s13741-025-00545-5.
2
Impact of graft type on outcomes following liver transplantation for primary sclerosing cholangitis.移植物类型对原发性硬化性胆管炎肝移植术后结局的影响。
Hepatol Int. 2025 Feb;19(1):244-255. doi: 10.1007/s12072-024-10733-y. Epub 2024 Oct 30.
3
Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population.

本文引用的文献

1
Early changes in kidney function predict long-term chronic kidney disease and mortality in patients after liver transplantation.早期肾功能变化可预测肝移植后患者的长期慢性肾脏病和死亡率。
Transplantation. 2011 Dec 27;92(12):1358-63. doi: 10.1097/TP.0b013e3182384aff.
2
Impact of MELD-based allocation on end-stage renal disease after liver transplantation.基于 MELD 评分的肝移植后终末期肾病的影响。
Am J Transplant. 2011 Nov;11(11):2372-8. doi: 10.1111/j.1600-6143.2011.03703.x. Epub 2011 Aug 22.
3
Chronic kidney disease after orthotopic liver transplantation: impact of hepatitis C infection.
在移植人群中,持续特利加压素输注治疗肝肾综合征伴急性肾损伤的安全性和有效性。
Liver Transpl. 2024 Oct 1;30(10):1026-1038. doi: 10.1097/LVT.0000000000000399. Epub 2024 May 22.
4
Novel indications for referral and care for simultaneous liver kidney transplant recipients.为肝肾联合移植受者转诊和治疗提供新的适应证。
Curr Opin Nephrol Hypertens. 2024 May 1;33(3):354-360. doi: 10.1097/MNH.0000000000000970. Epub 2024 Feb 12.
5
Risk Factors and Prognosis of New-Onset Chronic Kidney Disease Following Orthotopic Liver Transplantation: A Retrospective Case-Control Study.原位肝移植术后新发慢性肾脏病的危险因素和预后:一项回顾性病例对照研究。
Med Sci Monit. 2021 Sep 19;27:e931834. doi: 10.12659/MSM.931834.
6
Chronic renal dysfunction in cirrhosis: A new frontier in hepatology.肝硬化中的慢性肾功能障碍:肝病学的新前沿。
World J Gastroenterol. 2021 Mar 21;27(11):990-1005. doi: 10.3748/wjg.v27.i11.990.
7
A comparison of rates and severity of chronic kidney disease in deceased-donor and living-donor liver transplant recipients: times matter.比较死亡供体和活体供体肝移植受者的慢性肾脏病发生率和严重程度:时间很重要。
Turk J Med Sci. 2021 Apr 30;51(2):610-622. doi: 10.3906/sag-2007-82.
8
Longitudinal Renal Function in Liver Transplant Recipients With Acute-on-Chronic Liver Failure.慢性加急性肝衰竭肝移植受者的纵向肾功能。
Clin Transl Gastroenterol. 2020 Jun;11(6):e00185. doi: 10.14309/ctg.0000000000000185.
9
The proportion of Model for End-stage Liver Disease Sodium score attributable to creatinine independently predicts post-transplant survival and renal complications.终末期肝病钠评分中归因于肌酐的比例可独立预测移植后的生存率和肾脏并发症。
Clin Transplant. 2020 Mar;34(3):e13817. doi: 10.1111/ctr.13817. Epub 2020 Feb 20.
10
Outcomes of Liver Transplantation in Patients on Renal Replacement Therapy: Considerations for Simultaneous Liver Kidney Transplantation Versus Safety Net.接受肾脏替代治疗的患者肝移植的结局:同期肝肾联合移植与安全网的考量
Transplant Direct. 2019 Sep 19;5(10):e490. doi: 10.1097/TXD.0000000000000935. eCollection 2019 Oct.
原位肝移植后慢性肾脏病:丙型肝炎感染的影响。
Transplantation. 2011 Jun 15;91(11):1245-9. doi: 10.1097/TP.0b013e318218d5bd.
4
Simultaneous liver kidney transplantation: a medical decision analysis.肝肾联合移植:医学决策分析。
Transplantation. 2011 Jan 15;91(1):121-7. doi: 10.1097/tp.0b013e3181fcc943.
5
Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis.工作组关于修订肝硬化患者肾功能障碍分类系统的建议。
Gut. 2011 May;60(5):702-9. doi: 10.1136/gut.2010.236133. Epub 2011 Feb 15.
6
Association of trypanolytic ApoL1 variants with kidney disease in African Americans.载脂蛋白 L1 变体与非裔美国人肾脏疾病的关联。
Science. 2010 Aug 13;329(5993):841-5. doi: 10.1126/science.1193032. Epub 2010 Jul 15.
7
Outcomes after liver transplantation: chronic kidney disease.肝移植后的结果:慢性肾脏病。
Liver Transpl. 2009 Nov;15 Suppl 2:S70-4. doi: 10.1002/lt.21900.
8
Renal outcomes after liver transplantation in the model for end-stage liver disease era.终末期肝病模型时代肝移植后的肾脏结局
Liver Transpl. 2009 Sep;15(9):1142-8. doi: 10.1002/lt.21821.
9
Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK).肝肾联合移植共识会议论文集
Am J Transplant. 2008 Nov;8(11):2243-51. doi: 10.1111/j.1600-6143.2008.02416.x. Epub 2008 Sep 19.
10
Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: ineffective usage of renal allografts.终末期肝病模型(MELD)时代肝肾联合移植的疗效下降:肾移植受者的无效使用
Transplantation. 2008 Apr 15;85(7):935-42. doi: 10.1097/TP.0b013e318168476d.